NCT00932932已完成不适用
11 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
Children's Mercy Hospital Kansas City0 个研究点目标入组 36 人开始时间: 2009年2月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
The purpose of the study is to find out if people with Prader-Willi syndrome have a difference in the protein which changes inactive cortisone to the active stress hormone cortisol.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Months 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Prader-Willi syndrome confirmed by molecular testing, ages 6 months to adult
- •Controls: Age-matched, sex-matched, developmentally normal, BMI-controlled healthy or obese subjects
排除标准
- •PWS subjects without molecular confirmation of the diagnosis
- •Subjects receiving glucocorticoid treatment within 3 months of evaluation
- •Subjects receiving growth hormone within one year prior to analysis
研究者
相似试验
已完成
1 期
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62Type 2 Diabetes Mellitus in ObeseType2DiabetesObesityNCT05409027Sparrow Pharmaceuticals12
已完成
1 期
Oxytocin Trial in Prader-Willi SyndromePrader Willi SyndromeNCT02013258University of Florida24
已完成
不适用
Characteristics of Prader-Willi Syndrome and Early-onset Morbid ObesityPrader-Willi SyndromeObesityNCT00375089University of Florida392
已完成
3 期
Growth Hormone Use in Adults With Prader-Willi SyndromePrader-Willi SyndromeNCT00444964Children's Mercy Hospital Kansas City11
已完成
不适用
Suspected Deficient Activation of Vitamin D in Patients With Secondary HyperparathyroidismSecondary HyperparathyroidismNCT00754442University of Maryland, Baltimore20